Crissy Fellabaum

2.8k total citations · 3 hit papers
27 papers, 2.1k citations indexed

About

Crissy Fellabaum is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Crissy Fellabaum has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Crissy Fellabaum's work include Mesenchymal stem cell research (12 papers), Extracellular vesicles in disease (6 papers) and MicroRNA in disease regulation (4 papers). Crissy Fellabaum is often cited by papers focused on Mesenchymal stem cell research (12 papers), Extracellular vesicles in disease (6 papers) and MicroRNA in disease regulation (4 papers). Crissy Fellabaum collaborates with scholars based in Serbia, Switzerland and United States. Crissy Fellabaum's co-authors include Carl Randall Harrell, Vladislav Volarević, Valentin Djonov, Nebojša Arsenijević, Bojana Simović Marković, Marina Gazdic, Nemanja Jovičić, Aleksandar Arsenijević, Ruxana T. Sadikot and José L. Pascual and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Theranostics.

In The Last Decade

Crissy Fellabaum

26 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome

2019 364 citations Carl Randall Harrell, Crissy Fellabaum et al. Cells profile →
Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity

2019 340 citations Vladislav Volarević, Marina Gazdic et al. Journal of Biomedical Science profile →
Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives

2018 223 citations Carl Randall Harrell, Bojana Simović Marković et al. Biomedicine & Pharmacotherapy profile →

Peers

Crissy Fellabaum

GENET

SURGE

PFM

Carl Randall Harrell Serbia

Marina Gazdic Serbia

Benedetta Mazzanti Italy

Satoru Morikawa Japan

Guangqian Zhou China

Jinsong Wang China

Giovanni Marfia Italy

Huiyong Shen China

Zhifeng Gu China

Jelena Krstić Serbia

Carl Randall Harrell Serbia

Crissy Fellabaum

1.5k ×1.9

1.1k ×1.4

GENET

525 ×1.4

SURGE

354 ×1.1

PFM

602 ×2.2

Citations per year, relative to Crissy Fellabaum Crissy Fellabaum (= 1×) peers Carl Randall Harrell

Countries citing papers authored by Crissy Fellabaum

Since Specialization

Citations

This map shows the geographic impact of Crissy Fellabaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Crissy Fellabaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Crissy Fellabaum more than expected).

Fields of papers citing papers by Crissy Fellabaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Crissy Fellabaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Crissy Fellabaum. The network helps show where Crissy Fellabaum may publish in the future.

Co-authorship network of co-authors of Crissy Fellabaum

This figure shows the co-authorship network connecting the top 25 collaborators of Crissy Fellabaum. A scholar is included among the top collaborators of Crissy Fellabaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Crissy Fellabaum. Crissy Fellabaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Volarević, Vladislav, et al.. (2025). Therapeutic Potential of Chimeric Antigen Receptor-Expressing Mesenchymal Stem Cells in the Treatment of Inflammatory and Autoimmune Diseases. International Journal of Molecular Sciences. 26(16). 7795–7795.

Harrell, Carl Randall, Crissy Fellabaum, Bojana Simović Marković, et al.. (2021). Therapeutic Potential of „Derived-Multiple Allogeneic Proteins Paracrine Signaling-D-Mapps” in the Treatment of Dry Eye Disease. SHILAP Revista de lepidopterología. 23(2). 167–173. 5 indexed citations

Harrell, Carl Randall, Ruxana T. Sadikot, Crissy Fellabaum, et al.. (2020). Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation. Analytical Cellular Pathology. 2020. 1–15. 59 indexed citations

Gazdic, Marina, et al.. (2019). New Insights in the Pathogenesis of Cisplatin-induced Nephrotoxicity. 25(3). 275–284. 2 indexed citations

Volarević, Vladislav, Marina Gazdic, Carl Randall Harrell, et al.. (2019). Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. Journal of Biomedical Science. 26(1). 25–25. 340 indexed citations breakdown →

Volarević, Vladislav, Bojana Simović Marković, Marina Gazdic, et al.. (2019). Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs. Theranostics. 9(20). 5976–6001. 41 indexed citations

Volarević, Vladislav, Nataša Zdravković, Carl Randall Harrell, et al.. (2019). Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis. Cells. 8(7). 709–709. 23 indexed citations

Harrell, Carl Randall, Ruxana T. Sadikot, José L. Pascual, et al.. (2019). Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives. Stem Cells International. 2019. 1–14. 159 indexed citations

Harrell, Carl Randall, Bojana Simović Marković, Crissy Fellabaum, et al.. (2018). Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases. Advances in experimental medicine and biology. 1089. 47–57. 79 indexed citations

10.

Harrell, Carl Randall, Marina Gazdic, Crissy Fellabaum, et al.. (2018). Molecular Mechanisms Responsible for Anti-inflammatory and Immunosuppressive Effects of Mesenchymal Stem Cell-Derived Factors. Advances in experimental medicine and biology. 1084. 187–206. 93 indexed citations

11.

Nikolić, Aleksandar, Bojana Simović Marković, Marina Gazdic, et al.. (2018). Intraperitoneal administration of mesenchymal stem cells ameliorates acute dextran sulfate sodium-induced colitis by suppressing dendritic cells. Biomedicine & Pharmacotherapy. 100. 426–432. 29 indexed citations

12.

Harrell, Carl Randall, Bojana Simović Marković, Crissy Fellabaum, Aleksandar Arsenijević, & Vladislav Volarević. (2018). Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives. Biomedicine & Pharmacotherapy. 109. 2318–2326. 223 indexed citations breakdown →

13.

Harrell, Carl Randall, Crissy Fellabaum, Bojana Simović Marković, Aleksandar Arsenijević, & Vladislav Volarević. (2018). Therapeutic Potential of “Exosomes Derived Multiple Allogeneic Proteins Paracrine Signaling: Exosomes d-MAPPS” is Based on the Effects of Exosomes, Immunosuppressive and Trophic Factors. Serbian Journal of Experimental and Clinical Research. 20(3). 189–197. 19 indexed citations

14.

Jakovljevic, Jelena, Carl Randall Harrell, Crissy Fellabaum, et al.. (2018). Modulation of autophagy as new approach in mesenchymal stem cell-based therapy. Biomedicine & Pharmacotherapy. 104. 404–410. 52 indexed citations

15.

Harrell, Carl Randall, Bojana Simović Marković, Crissy Fellabaum, et al.. (2018). Molecular mechanisms underlying therapeutic potential of pericytes. Journal of Biomedical Science. 25(1). 21–21. 88 indexed citations

16.

Harrell, Carl Randall, Valentin Djonov, Crissy Fellabaum, & Vladislav Volarević. (2018). Risks of Using Sterilization by Gamma Radiation: The Other Side of the Coin. International Journal of Medical Sciences. 15(3). 274–279. 132 indexed citations

17.

Gazdic, Marina, Nemanja Jovičić, Carl Randall Harrell, et al.. (2018). Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract. Therapeutic Advances in Gastroenterology. 11. 3972004198–3972004198. 25 indexed citations

18.

Marković, Bojana Simović, Marina Gazdic, Aleksandar Arsenijević, et al.. (2018). Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis. Therapeutic Advances in Gastroenterology. 11. 3971982422–3971982422. 23 indexed citations

19.

Marković, Bojana Simović, Tatjana Kanjevac, Carl Randall Harrell, et al.. (2017). Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases. Stem Cell Reviews and Reports. 14(2). 153–165. 44 indexed citations

20.

Arsenijević, Aleksandar, Carl Randall Harrell, Crissy Fellabaum, & Vladislav Volarević. (2017). Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis. Analytical Cellular Pathology. 2017. 1–9. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact